- $3.83m
- $1.27m
- $9.93m
- 34
- 71
- 42
- 46
Annual cashflow statement for iSpecimen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -4.73 | -4.65 | -8.96 | -10.2 | -11.1 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.361 | 0.503 | 2.57 | 0.869 | 0.587 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.05 | 3.04 | -5.28 | 2.35 | 2.59 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -2.68 | -0.288 | -10.7 | -5.82 | -5.81 |
Capital Expenditures | -1.48 | -1.1 | -1.04 | -3.19 | -4.74 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | — | — | -2.48 |
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1.48 | -1.1 | -1.04 | -3.19 | -7.23 |
Financing Cash Flow Items | 0 | — | -2.37 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 3.08 | 2.03 | 38.7 | -3.42 | 0.071 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.08 | 0.642 | 27 | -12.4 | -13 |